Consultancy for institutions
and professionals.
Independent advisory for hospitals, clinics, regions and medical technology companies. Four decades of radiation oncology at the edges of what is treatable, applied to your clinical, technological and strategic questions.
Advisory board spanning 16+ institutions
Harvard Medical SchoolCNRS GrenobleNagasaki UniversityLoma Linda UniversityCentre Antoine LacassagneIllustrative representation. Not actual clinical data.
Eye preserved. Vision maintained.
24 months and counting.
The treating clinic requested an independent expert assessment after their tumor board recommended enucleation for recurrent uveal melanoma following prior brachytherapy.
Our advisory panel identified that the recurrence was localized enough for salvage proton therapy at Centre Antoine Lacassagne.
Three weeks from consultation to treatment start. The treating team could offer their patient an organ-preserving alternative with documented long-term follow-up.
Clinical Detail
Multidisciplinary review by radiation oncologists with proton therapy expertise from two continents. Tumor thickness 4.2 mm. The panel included specialists from Harvard Medical School and Centre Antoine Lacassagne with combined experience of over 12,000 ocular tumor patients.
Why It Matters
Expert assessment can change the trajectory of a case.
Rare and complex indications require pattern recognition that no single institution can build alone. An independent review from specialists who have seen hundreds of similar cases gives treating teams additional options to consider.
Advisory Board
Our advisory board includes specialists from Harvard, CNRS, Nagasaki University, Loma Linda, and former leadership at Varian Medical Systems. Each engagement draws on decades of combined experience in radiation oncology, particle therapy, and nuclear medicine.
See the full range of indications we consult on.
From ocular tumors to recurrent head and neck cancers.
How It Works
Three steps to an expert assessment.
01
Share the context
Your institution shares the clinical or technical context through our contact form. No sensitive patient data at this stage, just the medical or strategic question.
02
Expert review
We match the right specialists from our advisory board to your question. The review panel is tailored to the specific indication and discipline.
03
Structured written assessment
Your team receives a structured expert assessment with treatment or technology considerations, alternative approaches, and references to supporting evidence.
Our Service Lines
Three areas of expertise.
Clinical Advisory
Independent expert assessment for hospitals and treating physicians facing complex radiation oncology cases. Recurrent disease, re-irradiation decisions, rare indications.
View expertise areasCentre and Technology Advisory
Vendor-neutral guidance for hospitals, regions, and operators planning proton, BNCT, or accelerator-based treatment facilities. From feasibility through first patient.
Discuss a centre projectIndustry Advisory
For companies bringing irradiation systems using ions and neutrons into medicine. Clinical requirements, regulatory pathway, and market access guidance from four decades at the intersection of physics and oncology.
Discuss a project16+
Institutions
Advisory board members across leading centres.
3
Continents
Europe, Asia, North America.
40+
Years radiation oncology
At the edges of what is treatable.
As of 2026.
Cooperation Partners
Staila Polaris MedTech GmbH
Rolf Stähelin on LinkedIn
Take the next step
Complex questions deserve independent expertise.
Share the clinical or technical context. Our advisory board will match the right specialists to your question. No commitment required.